COVID-19 can result in cardiac complications including myocarditis, arterial and venous thromboembolism, and cardiomyopathy.
A presentation given at the Radiological Society of North America (RSNA) Annual Meeting on November 28th covered the cardiovascular imaging manifestations of COVID-19.
“SARS-CoV-2 is a novel coronavirus which primarily affects the respiratory system, but has also been shown to impact other systems, especially with the hypercoagulable state,” said Margaret Revzon, M.D., an associate professor of radiology and biomedical imaging at Yale School of Medicine, in New Haven, Conn. “The hypercoagulable state and resulted vascular complications are not uncommon in patients with COVID-19.”
COVID-19 can result in cardiac complications including myocarditis, arterial and venous thromboembolism, and cardiomyopathy. While ultrasound is the first imaging choice for these patients, computerized tomography (CT) can be selected, but clinicians must note that the COVID-19 patient is often in the prone position. Magnetic resonance imaging (MRI) can be used for complex cases. Dr. Revzon highlighted that awareness and recognition of imaging manifestations of COVID-19 induced thromboembolic complications will ensure optimal treatment for these patients.
Brian Burns Ghoshhajra, M.D., associate professor of radiology at Harvard medical School in Boston, Mass., said that “there is systematic inflammation, endothelial activation and direct myocardial effects of SARS-CoV-2.”
While cardiovascular imaging, including CT and MRI, play a key role, context and pre-test probably likely matter more than ever. Dr. Ghoshhajra suggested that radiology services should be optimized for cardiac imaging.
“COVID-19 doesn’t occur in a vacuum, so remember your basics and cast a wide diagnostic net of there is not an established COVID-19 diagnosis yet,” Dr. Ghoshhajra said.
There have also been infrequent emerging reports of myocarditis and myocardial injury in a minority of patients after COVID-19 vaccination.
Kate Hanneman, M.D., FRCPC, an associate professor in the department of medical imaging at Women's College Hospital in Toronto, Canada, explained that there are limited data on what cardiac imaging findings are expected in these patients. However, the pattern on imaging appears to be like myocarditis from other causes, but less extensive compared to other causes of myocarditis.
“The extent on imaging, based on the reports we have to date, appears to be relatively mild. So less extensive compared to some other causes of myocarditis,” Dr. Hanneman said.
For more coverage of RSNA 2021, click here.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 2
July 25th 2025In the second of a multi-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, share their perspectives on remote MRI safety protocols for ensuring screening accuracy and adherence to conditional implant guidelines as well as a rapid and effective response to adverse events.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 2
July 23rd 2025In the second part of a multi-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, discuss key sequences for abbreviated breast MRI and how it stacks up to other breast cancer screening modalities.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.